Provided by Tiger Trade Technology Pte. Ltd.

Recursion Pharmaceuticals, Inc.

3.84
-0.1750-4.36%
Post-market: 3.850.0150+0.39%17:43 EDT
Volume:19.71M
Turnover:76.75M
Market Cap:2.05B
PE:-3.75
High:4.05
Open:4.01
Low:3.82
Close:4.01
52wk High:7.18
52wk Low:2.77
Shares:535.00M
Float Shares:522.33M
Volume Ratio:0.49
T/O Rate:3.77%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.0219
EPS(LYR):-1.4410
ROE:-56.58%
ROA:-27.33%
PB:2.24
PE(LYR):-2.66

Loading ...

Oct 06, 2026

Proposed Sale Of Securities

Form 144 | RECURSION PHARMACEUTICALS Director Borgeson Blake proposes to sell 50,000 Shares, with a total value of approximately $242,000.
Oct 06, 2026

Proposed Sale Of Securities

Form 144 | Recursion Pharmaceuticals' Director Robert Hershberg proposes to sell 25,000 shares, with a total value of approximately $125,000.
Sep 21, 2026

Major Issues Report

Form 8-K - Current report
Sep 08, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 02, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 21, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 20, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 19, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 18, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 13, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 12, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 10, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 07, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Aug 07, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 05, 2026

Major Issues Report

Form 8-K - Current report
Aug 05, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 04, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 04, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 31, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Jul 31, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors